CLL (Chronic Lymphocytic Leukemia),Leukemia Safety of Subcutaneous Mosunetuzumab in Refractory B-Cell Lymphomas: Trial Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Mosunetuzumab Shows Promise in R/R Follicular Lymphoma Treatment: Phase II Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Long-Term Immune Changes in CLL with Venetoclax Plus Rituximab: MURANO Trial Mar 07, 2023
CML (Chronic Myeloid Leukemia),Leukemia Asciminib Outperforms Bosutinib in Long-Term CML-CP Treatment Feb 27, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia CLL14 Study: Cost-Effectiveness of VenO vs. ClbO Feb 27, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Improved Outcomes in High-Risk Relapsed B-ALL with Blinatumomab Feb 27, 2023
AML (Acute Myeloid Leukemia),Leukemia Oral Azacitidine for Long-Term AML Maintenance Therapy - Study Results Feb 27, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia,Lymphoma Comparing Relapsed or Refractory CLL with Zanubrutinib and Ibrutnib Phase 3 Trial Feb 16, 2023
